Cross Staff Investments’s Pfizer PFE Stock Holding History

Cross Staff Investments’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$319K	Buy	13,263 +326	+3%	+$8.53K	0.18%	111
2026 Q1	$363K	Buy	12,937 +1	+0%	+$27	0.18%	97
2025 Q4	$322K	Buy	12,936 +1	+0%	+$25	0.18%	102
2025 Q3	$330K	Buy	12,935 +1	+0%	+$25	0.23%	99
2025 Q2	$314K	Buy	12,934 +1	+0%	+$23	0.23%	101
2025 Q1	$328K	Hold	12,933	–	–	0.25%	95
2024 Q4	$343K	Buy	12,933 +1	+0%	+$27	0.24%	93
2024 Q3	$374K	Buy	12,932 +1	+0%	+$29	0.29%	89
2024 Q2	$362K	Buy	12,931 +1	+0%	+$28	0.3%	87
2024 Q1	$359K	Sell	12,930 -55	-0.4%	-$1.53K	0.3%	93
2023 Q4	$374K	Buy	12,985 +1	+0%	+$30	0.33%	85
2023 Q3	$431K	Buy	12,984 +24	+0.2%	+$849	0.42%	68
2023 Q2	$475K	Buy	12,960 +33	+0.3%	+$1.28K	0.44%	65
2023 Q1	$527K	Hold	12,927	–	–	0.52%	56
2022 Q4	$662K	Buy	12,927 +1	+0%	+$48	0.69%	47
2022 Q3	$566K	Hold	12,926	–	–	0.63%	45
2022 Q2	$678K	Hold	12,926	–	–	0.75%	39
2022 Q1	$669K	Buy	12,926 +1	+0%	+$52	0.62%	42
2021 Q4	$763K	Buy	+12,925	New	+$640K	0.68%	36

Other funds holding PFE

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

SLAM

Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Cross Staff Investments's PFE Position: Q2 2026 in Review

Cross Staff Investments increased its Pfizer (PFE) stake by 2.5% in Q2 2026, buying an estimated $8.53K and bringing the position to 13,263 shares worth $319K. The position accounts for 0.18% of the portfolio, ranked #111.

Cross Staff Investments first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $763K in Q4 2021. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Cross Staff Investments held 13,263 shares of Pfizer worth $319K as of Q2 2026.
Cross Staff Investments bought 326 Pfizer shares in Q2 2026, an estimated $8.53K.
Pfizer made up 0.18% of Cross Staff Investments's portfolio in Q2 2026, its #111 holding.
Cross Staff Investments first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
Cross Staff Investments's Pfizer position peaked at $763K in Q4 2021.
1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Cross Staff Investments's 13F filing for Q2 2026, filed 22 Jul 2026.